The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients
about
The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trialThe role of 5-HT on the cardiovascular and renal systems and the clinical potential of 5-HT modulation.Sarpogrelate: cardiovascular and renal clinical potential.Reduced albuminuria with sarpogrelate is accompanied by a decrease in monocyte chemoattractant protein-1 levels in type 2 diabetes.Diabetes-induced changes in the 5-hydroxytryptamine inhibitory receptors involved in the pressor effect elicited by sympathetic stimulation in the pithed rat.Blockade of 5-HT(2A) receptors by sarpogrelate protects the heart against myocardial infarction in rats.Beneficial effects of sarpogrelate hydrochloride, a 5-HT2A receptor antagonist, supplemented with pioglitazone on diabetic model mice.Effect of the potent CYP2D6 inhibitor sarpogrelate on the pharmacokinetics and pharmacodynamics of metoprolol in healthy male Korean volunteers.
P2860
Q34477919-46EF2975-05DC-414E-BCF4-19DB71D92222Q35117079-B3E462E6-9B6A-491D-BC5C-EADE793FF4F4Q35814472-E17D91ED-D1AF-4C9C-8451-8CB7305C2727Q36666799-558F308A-8C8E-4F81-8896-015791221E7AQ42127455-8DFC2CEE-84F2-4591-B858-1D8B2C1C5490Q43986745-465DB9DB-92D5-4E99-82C7-5DAC53130B67Q45951652-B61BB0CC-CFEB-43AF-A614-1636FBE0D7A4Q53257546-88217623-9B81-41ED-888F-D258F792698D
P2860
The 5-HT2 receptor antagonist sarpogrelate reduces urinary and plasma levels of thromboxane A2 and urinary albumin excretion in non-insulin-dependent diabetes mellitus patients
description
1999 nî lūn-bûn
@nan
1999 թուականին հրատարակուած գիտական յօդուած
@hyw
1999 թվականին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The 5-HT2 receptor antagonist ...... ent diabetes mellitus patients
@ast
The 5-HT2 receptor antagonist ...... ent diabetes mellitus patients
@en
The 5-HT2 receptor antagonist ...... ent diabetes mellitus patients
@nl
type
label
The 5-HT2 receptor antagonist ...... ent diabetes mellitus patients
@ast
The 5-HT2 receptor antagonist ...... ent diabetes mellitus patients
@en
The 5-HT2 receptor antagonist ...... ent diabetes mellitus patients
@nl
prefLabel
The 5-HT2 receptor antagonist ...... ent diabetes mellitus patients
@ast
The 5-HT2 receptor antagonist ...... ent diabetes mellitus patients
@en
The 5-HT2 receptor antagonist ...... ent diabetes mellitus patients
@nl
P2093
P1476
The 5-HT2 receptor antagonist ...... ent diabetes mellitus patients
@en
P2093
K Sugimura
K Takeuchi
P356
10.1111/J.1440-1681.1999.03056.X
P407
P577
1999-01-01T00:00:00Z